Corona News Bulletins
Thursday, 26 January 2023
FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants
Many take Evusheld as an additional layer of protection because the vaccines do not trigger a strong immune response for them.
from Health and Science https://ift.tt/XKIpFu2
https://ift.tt/Op0yeqC
https://ift.tt/cJjgwVR
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment